National Institutes of Health (NIH)
309 articles with National Institutes of Health (NIH)
Disc Medicine Announces Collaboration with National Institutes of Health for Phase 2 Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA)
Disc Medicine, Inc. announced a collaboration with the National Heart Lung and Blood Institute of the National Institutes of Health to evaluate bitopertin, a therapeutic candidate designed to modulate heme biosynthesis, in a phase 2 clinical study of patients with Diamond-Blackfan anemia.
Team Aims to Transform Care for Diffuse Intrinsic Pontine Glioma
Researchers at Children’s Hospital Los Angeles have received a nearly $1 million K08 grant from the National Institutes of Health —as well as funding from the U.S. Department of Defense—to support studies into diffuse intrinsic pontine glioma, a childhood brain tumor with a 0% survival rate.
NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS)
NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced an agreement with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health, to develop NeoImmuneTech's main asset NT-I7, for the treatment of Acute Radiation Syndrome.
Albert Einstein College of Medicine and Montefiore Health System Receive $5.2 Million NIH Grant to Study Heart Failure in Hispanic Populations
Cardiology researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $5.2 million grant from the National Institutes of Health to explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease.
Berkshire Biomedical Awarded Phase II Funding for NIH Research Grant to Support Continued Development of the COPA™ System for Automated at Home Methadone Administration
Berkshire Biomedical Corporation today announced that it has been awarded the second phase of a two-phase Fast-Track Small Business Innovation Research (SBIR) grant (1R44DA057185-01) from the National Institutes of Health's (NIH) National Institute of Drug Abuse (NIDA).
SCYNEXIS Announces $3 Million National Institutes of Health Grant Has Been Awarded to Case Western Reserve University Researchers to Study Second Generation Fungerp (SCY-247) to Fight Drug-Resistant Fungi
SCYNEXIS, Inc. today announced that researchers from Case Western Reserve University in Cleveland have been awarded a competitive research grant of more than $3 million by the National Institutes of Health (NIH), to investigate a second generation fungerp (SCY-247).
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer.
Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute to Study TIL Therapy in Combination with Viral Immunotherapy
Turnstone Biologics Corp today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to evaluate the generation of tumor-reactive T-cells, which form the basis of Turnstone’s tumor-infiltrating lymphocyte platform.
Spaulding Rehabilitation Hospital and Highland Instruments, Inc., Jointly Announce National Institutes of Health Funded Clinical Trial Investigating Highland's Electrosonic Stimulation Technology to Treat Carpal Tunnel Syndrome
Spaulding Rehabilitation Hospital, a teaching affiliate of Harvard Medical School, and Highland Instruments, Inc., jointly announced the advancement into Phase II of their National Institutes of Health funded Clinical Trial investigating Highland Instruments' Electrosonic Stimulation, a novel noninvasive brain stimulation technology, to treat Carpal Tunnel Syndrome1.
FIU wins $19.4M NIH grant to fight health disparities
Florida International University researchers are at the forefront of ensuring the health and well-being of underserved communities don't slip through the cracks.
ABL Awarded $Multimillion Contract to Provide Manufacturing and Nonclinical Services to Support Development of Promising Therapeutics for the NINDS
Advanced BioScience Laboratories announced it is one of three contractors awarded an Indefinite Delivery, Indefinite Quantity contract for "Manufacturing and Nonclinical Studies support for Development of Therapeutic Biotechnology Products for Neurological-related Disorders" by the NINDS of the NIH of the HHS.
ABL Awarded NIH Contract for Continued Support of HIV Vaccine Development
Advanced BioScience Laboratories announced it has been awarded a contract for "Preclinical and translational vaccine development for HIV and other candidate agents" by the Division of AIDS within the National Institute of Allergy and Infectious Disease of the National Institutes of Health.
Vivasc Therapeutics Inc. Receives Its Second NIH Phase I STTR Grant With the Goal of Reversing the Molecular Causes of Heart Failure
Vivasc Therapeutics Inc. is pleased to announce it has initiated its second NIH Phase I STTR research grant, in conjunction with Georgetown University.
Trethera Receives $1.6 Million National Eye Institute Grant for Continued Advancement of TRE-515 Optic Neuritis Program
Trethera Corporation announced that the National Eye Institute, a division of the National Institutes of Health, has awarded Trethera a $1.6 million Fast-Track STTR commercialization grant to further develop TRE-515 as a treatment for optic neuritis.
The FNIH Announces New Research Initiative to Identify More Precise Treatment Strategies for Patients Suffering from Heart Failure
The Foundation for the National Institutes of Health and the National Heart Lung and Blood Institute at the National Institutes of Health are launching a new partnership to investigate the syndrome of heart failure with preserved ejection fraction.
FDA and NIH Launch Public-Private Partnership for Rare Neurodegenerative Diseases
Today, the U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare Neurodegenerative Diseases (CP-RND).
National Institute of Health (NIH) awards Matregenix a Phase 1 SBIR grant to develop a new dental barrier membrane for guided bone regeneration
Matregenix announces a grant award from the National Institute of Dental & Craniofacial Research under the auspices of the Small Business Innovation Research program and National Institutes of Health.
NIH Program Study Finds Pregnant People Are Exposed to Dangerous Chemicals Found in a Variety of Household Products
A new National Institutes of Health -funded study found that pregnant people are exposed to a variety of dangerous chemicals commonly found in household products.
Despite being the largest minority group in the United States, the contributions of disabled people are remarkedly underreported in the life sciences industry.
National Institutes of Health Awards Arkansas Children's Research Institute, Children's Hospital of Philadelphia $9.7 Million for Antifungal Therapy Study
Scientists at Arkansas Children's Research Institute and Children's Hospital of Philadelphia will use $9.7 million in funding from the National Institutes of Health to conduct a first-of-its-kind study to determine if a shorter course of therapy effectively treats uncomplicated candidemia, the most common invasive fungal disease in children.